Immunoediting the cancer genome--a new approach for personalized cancer therapy?

Vijay Shankaran, Hiroaki Ikeda, Allen T. Bruce, J. Michael White, Paul E. Swanson, Lloyd J. Old, Robert D. Schreiber, IFNγ, and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature. ,vol. 410, pp. 1107- 1111 ,(2001) , 10.1038/35074122

Steven A Rosenberg, James C Yang, Nicholas P Restifo, Cancer immunotherapy: moving beyond current vaccines Nature Medicine. ,vol. 10, pp. 909- 915 ,(2004) , 10.1038/NM1100

Gavin P. Dunn, Lloyd J. Old, Robert D. Schreiber, The Three Es of Cancer Immunoediting Annual Review of Immunology. ,vol. 22, pp. 329- 360 ,(2004) , 10.1146/ANNUREV.IMMUNOL.22.012703.104803

Jérôme Galon, Anne Costes, Fatima Sanchez-Cabo, Amos Kirilovsky, Bernhard Mlecnik, Christine Lagorce-Pagès, Marie Tosolini, Matthieu Camus, Anne Berger, Philippe Wind, Franck Zinzindohoué, Patrick Bruneval, Paul-Henri Cugnenc, Zlatko Trajanoski, Wolf-Herman Fridman, Franck Pagès, Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome Science. ,vol. 313, pp. 1960- 1964 ,(2006) , 10.1126/SCIENCE.1129139

Rong Rong Huang, Jason Jalil, James S. Economou, Bartosz Chmielowski, Richard C. Koya, Stephen Mok, Hooman Sazegar, Elizabeth Seja, Arturo Villanueva, Jesus Gomez-Navarro, John A. Glaspy, Alistair J. Cochran, Antoni Ribas, CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans Clinical Cancer Research. ,vol. 17, pp. 4101- 4109 ,(2011) , 10.1158/1078-0432.CCR-11-0407